HealthBlawg

David Harlow's Health Care Law Blog

    • Twitter
    • Facebook
    • LinkedIn
    • RSS
    • Email
  • About
  • Archives
  • Podcast
  • Press
  • Awards/Reviews
  • HIPAA
  • HCSM

Maybe Dr. Drug Rep wasn't doing such a disservice to humanity

January 3, 2008

In today’s email:

“The Debate of Influencing Doctors’ Decisions: Are Drug Characteristics the Missing Link?” is featured in the November 2007 edition of Management Science. The study was produced independently of the pharmaceutical industry, and may have important implications for policy makers and authorities exploring the way marketing affects drug dispensation, the researchers say.

The authors’ analysis is based on an examination of data provided by a large firm specializing in pharmaceutical marketing and clinical trial reports from the National Institute for Health and Clinical Excellence. The data yield five key findings, all of which illuminate how marketing affects doctors’ decision-making:

  • Marketing efforts are more successful for more effective drugs than less effective drugs.
  • Excessive marketing efforts can actually lower the distribution of less effective drugs.
  • Marketing efforts are more successful for drugs with more side effects than drugs with fewer side effects.
  • Physicians will accommodate requests more often for drugs with fewer side effects.
  • Physicians are more responsive to patient requests for more effective drugs.

“There is evidence that physicians rely on science while prescribing,” [one of the authors] said. “If a drug has many side effects, it’s best to have a sales rep explain those side effects directly to a doctor rather than firms bypassing medical professionals with ads aimed at patients.”

Fascinating findings.  It will be interesting to see if they are borne out by further research.  Maybe Dr. Drug Rep’s self-flagellation a month or so ago (see HealthBlawg post on that and related subjects here) was unwarranted after all.

— David Harlow

Filed Under: Health care policy, Health Law, Medical Ethics, Physicians, Prescription Drugs

you might also like:

  1. To negotiate or not to negotiate – That is the Medicare drug benefit question

  2. Prescription drug coverage may be cut from Massachusetts universal health care plan

  3. Massachusetts State Rep. Ruth Balser speaks with David Harlow about health reform, the Massachusetts experience, and potential implications for the federal effort

« ERISA pre-emption ruling bites San Fran health care coverage mandate
Another Blawg Review from across the pond »

Follow me on Twitter

Tweets by healthblawg

HIPAAtools

Hipaatools

The HIPAA Compliance Toolkit

The Walking Gallery

The Walking Gallery

Quick Links

  • Home
  • Categories
  • Archives
  • Podcast Interviews
  • HIPAAtools
  • HIPAA Compliance
  • Health Care Social Media
  • Speaking
  • In the Press
  • Blogroll

David Harlow

David Harlow

HealthcareNOW Radio

Connect with David

  • Twitter
  • Facebook
  • LinkedIn
  • RSS
  • Email
  • Subscribe
  • Contact
  • Book Me: Speaking
  • About
  • The Harlow Group LLC
Copyright © 2006–2021
HealthBlawg is a publication of The Harlow Group LLC. See Copyright notice and disclaimer.
Fair use with attribution and a link is encouraged. Click for more on David Harlow.
[footer_backtotop text="Back to top" href="#"]